Semax Nasal 10 mg
Also known as · Semax Nasal Spray
Pre-filled nasal-spray format of Semax — the intranasal delivery route studied in the Russian clinical literature.
Chemistry quick-facts
- CAS
- 80714-61-0
- Formula
- C37H51N9O10S
- MW
- 813.94 Da
- Length
- 7 aa
- Status
- Intranasal formulation — matches the Russian-registered clinical delivery route. Research use only outside Russia.
- Purity (HPLC)
- ≥ 99.0%
Mechanism of action
As per Semax 11 mg vial.
Research context
Nasal-spray formulation of Semax. The intranasal route was historically the clinical delivery method in Russian studies of this peptide.
Published studies
A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.
Reconstitution
- Solvent
- Pre-reconstituted
- Typical volume
- N/A
Storage
- Lyophilised
- 2–8 °C, upright, sealed.
- Reconstituted
- Same as sealed — pre-formulated.
- Shelf life — sealed
- 18 months refrigerated.
This page summarises the research literature on Semax Nasal 10 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.
- ResearchSemax 11 mg
Semax is a synthetic heptapeptide analogue of ACTH(4-10). Registered in Russia for stroke and cognitive indications; Western research-use only.
- ResearchSelank Nasal 10 mg
Pre-filled nasal-spray format of Selank — matches the Russian clinical intranasal route.
- ResearchSelank 11 mg
Selank is a synthetic heptapeptide analogue of tuftsin. Registered in Russia as a non-benzodiazepine anxiolytic; Western research-use only.